SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes - Bajaj, H.S.; Brown, R.E.; Bhullar, L.; Sohi, N.; Kalra, S.; Aronson, R. (Diabetes & metabolism, 2018)
Keywords: Aged; Aged, 80 and over; Alanine aminotransferase; Alanine Transaminase - blood; Antihyperglycaemic agents; Benzhydryl Compounds - therapeutic use; Canada; Canagliflozin - therapeutic use; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Female; Glucosides - therapeutic use; Humans; Hypoglycemic Agents - therapeutic use; Incretins - therapeutic use; Liraglutide - therapeutic use; Male; Middle Aged; Non-alcoholic fatty liver disease; Registries; Retrospective Studies; SGLT2 inhibitors; Sitagliptin Phosphate - therapeutic use; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Treatment Outcome; Type 2 diabetes; Canada; Type 2 diabetes; Alanine aminotransferase; Antihyperglycaemic agents; Non-alcoholic fatty liver disease; SGLT2 inhibitors